6NL-30892-90866
3 vaccinations
6 coded responses
28 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 034 / NH
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
- 2021-01-14
- 2021-01-15
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Headache, Pre-existing disease — Feeling: Good · HeadacheFree text: I get headaches regularly, feels consistent with my baselineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
- 2021-01-28
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Muscle or body achesAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-06
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-26
- 2021-03-05
- 2021-03-11
- 2021-03-19
- 2021-08-04
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tirednessFree text: Significant axillary lymphadenopathy in arm of injection; very swollen and painfulMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · Fatigue or tirednessFree text: Still having significant axillary lymphadenopathy in injected armMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
-
2021-10-07
Survey response — day 7, dose 3MedDRA: Migraine — Feeling: Fair · HeadacheFree text: I get migraines at baseline, do not have any reason to suspect relation to booster doseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-14
Survey response — day 14, dose 3MedDRA: Rash — Feeling: GoodFree text: Starting to have random rashes on face/chest/neck. Does not feel related to vaccine but who can sayMedDRA releases: 2024-11 · check-in free text available
- 2021-10-19
- 2021-10-26
- 2021-11-04
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Dyspnoea, Flushing, Postural orthostatic tachycardia syndrome, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I get episodes of flushing, tachycardia, dyspnea. Suspicious for POTS, dont feel related to vaccine.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-05
Call successfulDoes not wish to fill out VAERS report
- 2022-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): I get headaches regularly, feels consistent with my baseline
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Significant axillary lymphadenopathy in arm of injection; very swollen and painful
Systemic reaction (other): Still having significant axillary lymphadenopathy in injected arm
Release 10 — day 7, dose 3
Systemic reaction (other): I get migraines at baseline, do not have any reason to suspect relation to booster dose
Release 10 — day 14, dose 3
Symptoms: Starting to have random rashes on face/chest/neck. Does not feel related to vaccine but who can say
Release 10 — 3 months, dose 3
Symptoms: I get episodes of flushing, tachycardia, dyspnea. Suspicious for POTS, dont feel related to vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Flushing | · | · | ✓ |
| SD | Postural orthostatic tachycardia syndrome | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Migraine | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release